Cyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review)

Por HAN, YEMING, ZHAN, YANG, HOU, GUIHUA, LI, LI
Publicado em 2014

TRAF3: a novel tumor suppressor gene in macrophages

Por Lalani, Almin I., Luo, Chang, Han, Yeming, Xie, Ping
Publicado no Macrophage (Houst) (2015)

Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation

Por Han, Yeming, Zhao, Shanshan, Gong, Yaoqin, Hou, Guihua, Li, Xi, Li, Li
Publicado no Oncotarget (2015)

Down-regulating cyclin-dependent kinase 9 of alloreactive CD4(+) T cells prolongs allograft survival

Por Zhan, Yang, Han, Yeming, Sun, Hukui, Liang, Ting, Zhang, Chao, Song, Jing, Hou, Guihua
Publicado no Oncotarget (2016)

MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C

Por Xu, Zhiliang, Han, Yeming, Liu, Jiying, Jiang, Fan, Hu, Huili, Wang, Yan, Liu, Qiji, Gong, Yaoqin, Li, Xi
Publicado no Sci Rep (2015)

Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells

Por Edwards, Shanique K.E., Han, Yeming, Liu, Yingying, Kreider, Benjamin Z., Liu, Yan, Grewal, Sukhdeep, Desai, Anand, Baron, Jacqueline, Moore, Carissa R., Luo, Chang, Xie, Ping
Publicado no Leuk Res (2015)